Lexicon Pharmaceuticals, INC. (LXRX) SEC Filings — 2025

Filings

• Lexicon Pharmaceuticals, INC. 8-K Filing — 8-K · Nov 10, 2025
• Lexicon Pharmaceuticals Files 8-K Report — 8-K · Nov 6, 2025
• Lexicon Narrows Losses on Novo Nordisk Deal, Cuts Spending — 10-Q · Nov 6, 2025
• Lexicon Pharmaceuticals Files 8-K on Financials — 8-K · Aug 6, 2025
• Lexicon's Losses Widen Amid Rising R&D Costs — 10-Q · Aug 6, 2025
• Lexicon Sells Inhaled Program for $100M — 8-K · Jul 28, 2025
• Lexicon Pharmaceuticals Files 8-K — 8-K · Jul 3, 2025
• Lexicon Pharmaceuticals Files 8-K on Material Agreement — 8-K · Jun 3, 2025
• Lexicon Pharmaceuticals, INC. 10-Q Filing — 10-Q · May 14, 2025
• Lexicon Pharmaceuticals Files 8-K on Financials — 8-K · May 13, 2025
• Lexicon Pharma Details 2024 Executive Compensation — DEF 14A · Apr 22, 2025
• Lexicon Pharmaceuticals Enters Material Definitive Agreement — 8-K · Mar 28, 2025
• Lexicon Pharmaceuticals, INC. 10-K Filing — 10-K · Mar 7, 2025
• Lexicon Pharmaceuticals Files 8-K on Financials — 8-K · Mar 6, 2025
• Lexicon Pharmaceuticals Faces Listing Rule Issues — 8-K · Jan 7, 2025
• Lexicon Pharma Appoints New CMO, Adds Director — 8-K · Jan 2, 2025